Claim
Reducing anti-TfR antibody affinity for transferrin receptor enhances receptor-mediated transcytosis and brain uptake; bispecific anti-TfR/BACE1 antibody lowers brain Aβ in mice after single systemic dose. Mechanistic foundation of the Brain Shuttle delivery class.
Yichao Yu et al. 2011, Science Translational Medicine
Evidence span
Reducing anti-TfR antibody affinity for transferrin receptor enhances receptor-mediated transcytosis and brain uptake; bispecific anti-TfR/BACE1 antibody lowers brain Aβ in mice after single systemic dose. Mechanistic foundation of the Brain Shuttle delivery class.
Method & conditions
- Evidence type
- experimental
- Method
- manual state transition; control details require source inspection
- Species
- source-reported model organism
- Conditions
- Mouse PK/PD; TfR-bispecific anti-BACE1 antibody. Affinity-engineered for transcytosis kinetics.
- Replicated
- not yet
Confidence basis
operator-supplied frontier prior; review required